Table 2.
HBV genotype frequencies and HCC survival
| HBV genotype | HCC Patients | Deaths | MST | Log‐rank | Crude HR | P value | Adjusted HR | P valuea |
|---|---|---|---|---|---|---|---|---|
| (n = 305) N (%) | (n = 238) N (%) | (mo) | P value | (95% CI) | (95% CI)a | |||
| Model 1 | ||||||||
| B | 44 (14.43) | 34 (11.15) | 13.54 | 1 | — | 1 | — | |
| BC | 25 (8.20) | 20 (6.56) | 14.29 | 0.644 | 1.11 (0.64‐1.93) | 0.705 | 0.74 (0.42‐1.31) | 0.298 |
| C | 236 (77.38) | 184 (60.33) | 14.69 | 0.617 | 0.91 (0.63‐1.32) | 0.620 | 0.86 (0.59‐1.25) | 0.423 |
| Model 2 | ||||||||
| B related | 69 (22.62) | 54 (17.70) | 14.29 | 1 | — | 1 | — | |
| Non‐B | 236 (77.38) | 184 (60.33) | 14.69 | 0.398 | 0.88 (0.65‐1.19) | 0.399 | 0.97 (0.71‐1.33) | 0.837 |
B related genotypes including B, BC. Non‐B genotypes including C, D. Abbreviation: HCC, hepatocellular carcinoma.
a
Cox proportional hazard regression analyses adjusted for age, gender, smoke, drink, BCLC stage, and chemotherapy or TACE.